Biological functions
Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
---|---|---|---|---|---|---|---|---|---|---|
BP | GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 34/1618 | 218/18670 | 0.0005678 | 0.02523 | 0.02199 | 34 | RABC14 | |
BP | GO:0071158 | positive regulation of cell cycle arrest | 17/1618 | 82/18670 | 0.0005693 | 0.02523 | 0.02199 | 17 | RABC14 | |
BP | GO:0003170 | heart valve development | 14/1618 | 61/18670 | 0.0005873 | 0.02584 | 0.02252 | 14 | RABC14 | |
BP | GO:0031343 | positive regulation of cell killing | 15/1618 | 68/18670 | 0.0005946 | 0.02596 | 0.02262 | 15 | RABC14 | |
BP | GO:2001233 | regulation of apoptotic signaling pathway | 55/1618 | 406/18670 | 0.0006012 | 0.02599 | 0.02265 | 55 | RABC14 | |
BP | GO:0098813 | nuclear chromosome segregation | 39/1618 | 262/18670 | 0.0006039 | 0.02599 | 0.02265 | 39 | RABC14 | |
BP | GO:0002711 | positive regulation of T cell mediated immunity | 12/1618 | 48/18670 | 0.0006296 | 0.02689 | 0.02344 | 12 | RABC14 | |
BP | GO:0048640 | negative regulation of developmental growth | 21/1618 | 113/18670 | 0.0006469 | 0.02735 | 0.02383 | 21 | RABC14 | |
BP | GO:0046426 | negative regulation of JAK-STAT cascade | 8/1618 | 24/18670 | 0.0006494 | 0.02735 | 0.02383 | 8 | RABC14 | |
BP | GO:0020027 | hemoglobin metabolic process | 6/1618 | 14/18670 | 0.0006843 | 0.02844 | 0.02478 | 6 | RABC14 | |
BP | GO:0060411 | cardiac septum morphogenesis | 16/1618 | 76/18670 | 0.000685 | 0.02844 | 0.02478 | 16 | RABC14 | |
BP | GO:0030900 | forebrain development | 52/1618 | 381/18670 | 0.0007029 | 0.02891 | 0.02519 | 52 | RABC14 | |
BP | GO:0050769 | positive regulation of neurogenesis | 62/1618 | 474/18670 | 0.0007062 | 0.02891 | 0.02519 | 62 | RABC14 | |
BP | GO:0003209 | cardiac atrium morphogenesis | 9/1618 | 30/18670 | 0.0007198 | 0.02926 | 0.0255 | 9 | RABC14 | |
BP | GO:0001909 | leukocyte mediated cytotoxicity | 20/1618 | 107/18670 | 0.0007979 | 0.03222 | 0.02807 | 20 | RABC14 | |
BP | GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 26/1618 | 155/18670 | 0.0008152 | 0.03269 | 0.02849 | 26 | RABC14 | |
BP | GO:0035710 | CD4-positive, alpha-beta T cell activation | 18/1618 | 92/18670 | 0.0008215 | 0.03272 | 0.02851 | 18 | RABC14 | |
BP | GO:0045930 | negative regulation of mitotic cell cycle | 47/1618 | 338/18670 | 0.0008302 | 0.03279 | 0.02857 | 47 | RABC14 | |
BP | GO:0071621 | granulocyte chemotaxis | 22/1618 | 123/18670 | 0.0008343 | 0.03279 | 0.02857 | 22 | RABC14 | |
BP | GO:0003183 | mitral valve morphogenesis | 5/1618 | 10/18670 | 0.0008444 | 0.03297 | 0.02873 | 5 | RABC14 | |
BP | GO:0030866 | cortical actin cytoskeleton organization | 11/1618 | 43/18670 | 0.0008533 | 0.03309 | 0.02884 | 11 | RABC14 | |
BP | GO:0042129 | regulation of T cell proliferation | 26/1618 | 156/18670 | 0.0008993 | 0.03465 | 0.03019 | 26 | RABC14 | |
BP | GO:0008643 | carbohydrate transport | 25/1618 | 148/18670 | 0.0009167 | 0.03499 | 0.03049 | 25 | RABC14 | |
BP | GO:0003018 | vascular process in circulatory system | 28/1618 | 173/18670 | 0.0009353 | 0.03499 | 0.03049 | 28 | RABC14 | |
BP | GO:0006691 | leukotriene metabolic process | 9/1618 | 31/18670 | 0.0009371 | 0.03499 | 0.03049 | 9 | RABC14 | |
BP | GO:0003073 | regulation of systemic arterial blood pressure | 18/1618 | 93/18670 | 0.0009377 | 0.03499 | 0.03049 | 18 | RABC14 | |
BP | GO:0046634 | regulation of alpha-beta T cell activation | 18/1618 | 93/18670 | 0.0009377 | 0.03499 | 0.03049 | 18 | RABC14 | |
BP | GO:0001667 | ameboidal-type cell migration | 60/1618 | 461/18670 | 0.0009655 | 0.03558 | 0.031 | 60 | RABC14 | |
BP | GO:0042743 | hydrogen peroxide metabolic process | 13/1618 | 57/18670 | 0.0009713 | 0.03558 | 0.031 | 13 | RABC14 | |
BP | GO:1901987 | regulation of cell cycle phase transition | 62/1618 | 480/18670 | 0.0009718 | 0.03558 | 0.031 | 62 | RABC14 |